Open Access

Is the polypill effective in primary prevention? The evidence.

Congress Presentation

About the speaker

Doctor Melvin Lafeber

University Medical Center Utrecht, Utrecht (Netherlands (The))
1 presentation
0 follower

3 more presentations in this session

Rationale for the use of the polypill in cardiovascular disease.

Speaker: Professor D. Grobbee (Utrecht, NL)


Is the polypill effective in secondary prevention? The evidence.

Speaker: Professor V. Barrios (Madrid, ES)


Practical implementation of the polypill, current status and future challenges.

Speaker: Professor J. Gonzalez Juanatey (Santiago de Compostela, ES)


Access the full session

The cardiovascular polypill: practical implementation

Speakers: Doctor M. Lafeber, Professor D. Grobbee, Professor V. Barrios, Professor J. Gonzalez Juanatey

About the event


EuroPrevent 2017

6 April - 8 April 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb